Results 301 to 310 of about 2,712,287 (341)
Some of the next articles are maybe not open access.
The lesson of chronic migraine
Neurological Sciences, 2015The hypothesis that central sensitization/allodynia is the common final mechanism responsible for the progression of migraine pain is supported by the possibility of tracing back to allodynic mechanisms the action of the main risk factors for chronic migraine validated by the recent literature.
Bonavita Vincenzo, De Simone Roberto.
openaire +3 more sources
Emerging treatment for chronic migraine and refractory chronic migraine
Expert Opinion on Emerging Drugs, 2012Chronic migraine (CM), the suffering of 15 or more headache days with at least 8 of these migraine days, afflicts 1.3% - 5.1% of the global population. CM is the most common disorder faced by experts in tertiary headache centers. When resistant to conventional medical treatment and prophylactic medication this condition is known as refractory chronic ...
Luana Lionetto +10 more
openaire +4 more sources
Chronic migraine: Classification and comparisons [PDF]
Cephalalgia, 2011 Objective: The objective of our study was to field test different chronic migraine (CM) criteria and compare CM epidemiological profiles, which include demographic, personal, and lifestyle characteristics, with high-frequency episodic migraine (HFEM) and low-frequency episodic migraine (LFEM). Methods: Questionnaires were mailed to a random sample of
Katsarava, Zaza +8 more
openaire +2 more sources
Revue Neurologique, 2013
The second edition of the International Classification of Headache Disorders revised in 2006 (ICHD-2R) gives a definition which requires 15 or more headache days per month over the past 3months with at least eight headache days per month that meet criteria for migraine without aura or that responds to migraine specific treatment.
openaire +5 more sources
The second edition of the International Classification of Headache Disorders revised in 2006 (ICHD-2R) gives a definition which requires 15 or more headache days per month over the past 3months with at least eight headache days per month that meet criteria for migraine without aura or that responds to migraine specific treatment.
openaire +5 more sources
Cephalalgia, 2020
Introduction Acute medication overuse is prevalent in patients with migraine. Methods In three phase 3, double-blind, randomized, placebo-controlled studies, patients with episodic migraine (EVOLVE-1 and EVOLVE-2) or chronic migraine (REGAIN) were ...
D. Dodick +7 more
semanticscholar +1 more source
Introduction Acute medication overuse is prevalent in patients with migraine. Methods In three phase 3, double-blind, randomized, placebo-controlled studies, patients with episodic migraine (EVOLVE-1 and EVOLVE-2) or chronic migraine (REGAIN) were ...
D. Dodick +7 more
semanticscholar +1 more source
Cephalalgia, 2020
Background This study reports the long-term safety and efficacy of erenumab in chronic migraine patients. Methods This was a 52-week open-label extension study of a 12-week double-blind treatment phase study.
S. Tepper +9 more
semanticscholar +1 more source
Background This study reports the long-term safety and efficacy of erenumab in chronic migraine patients. Methods This was a 52-week open-label extension study of a 12-week double-blind treatment phase study.
S. Tepper +9 more
semanticscholar +1 more source
Neuroimaging in chronic migraine
Neurological Sciences, 2010In chronic migraine, many neuroimaging studies with advanced techniques showed abnormalities in several brain areas involved in pain processing. The structural and functional dysfunctions are reported in cerebral areas localized in the brainstem and in the lateral and medial pain pathways.
Gennaro Bussone +3 more
openaire +3 more sources
BMJ, 2014
Chronic migraine is a disabling neurologic condition that affects 2% of the general population. Patients with chronic migraine have headaches on at least 15 days a month, with at least eight days a month on which their headaches and associated symptoms meet diagnostic criteria for migraine.
openaire +2 more sources
Chronic migraine is a disabling neurologic condition that affects 2% of the general population. Patients with chronic migraine have headaches on at least 15 days a month, with at least eight days a month on which their headaches and associated symptoms meet diagnostic criteria for migraine.
openaire +2 more sources
Proposed new diagnostic criteria for chronic migraine
Cephalalgia, 2020Introduction ICHD-3 criteria for chronic migraine (CM) include a mixture of migraine and tension-type-like headaches and do not account for patients who have a high frequency of migraine but no other headaches.
M. A. Chalmer +5 more
semanticscholar +1 more source
Cephalalgia, 2020
Background and purpose An estimated 2.5–3.1% of people with episodic migraine develop chronic migraine in a year. Several risk factors are associated with an increased risk for this transformation.
Jingjing Xu, Fanyi Kong, D. Buse
semanticscholar +1 more source
Background and purpose An estimated 2.5–3.1% of people with episodic migraine develop chronic migraine in a year. Several risk factors are associated with an increased risk for this transformation.
Jingjing Xu, Fanyi Kong, D. Buse
semanticscholar +1 more source